IRD Opus Genetics, Inc. logo

IRD Opus Genetics, Inc.

Healthcare
$4.09-3.99%ClosedMarket Cap: $332.9M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

7

Dispositions

7

Buy/Sell Ratio

1.00

Net Shares

-1,568,134

Shares Acquired

170,569

Shares Disposed

1,738,703

Total Bought ($)

$0.00

Total Sold ($)

$7.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Foundation Fighting Blindness Retinal Degeneration Funddirector, other: See RemarksSell1,700,000$4.353,792,171
Mon Apr 27Zaremba Rabourn Amyofficer: Head of Fin. Quality AssuranceSell1,641$5.20188,671
Mon Apr 27YERXA BENJAMIN Rdirector, officer: PresidentSell7,470$5.24711,535
Mon Apr 27SCHACHLE JOSEPH Kofficer: Chief Operating OfficerSell4,697$5.22296,084
Mon Apr 27Magrath Georgedirector, officer: Chief Executive OfficerSell9,511$5.221,741,344
Mon Apr 27Jayagopal Ashwathofficer: Chief Scientific & Dev. Ofc.Sell7,542$5.19509,233
Mon Apr 27Gagnon Robert E.officer: Chief Financial OfficerSell7,842$5.18592,158
Wed Apr 22Rodgers Richard JdirectorSell24,367$0.00343,022
Wed Apr 22MANUSO JAMES S JdirectorSell24,367$0.00317,318
Wed Apr 22Graves Adrienne LdirectorSell24,367$0.00127,514
Wed Apr 22Gallagher CamdirectorSell24,367$0.002,015,797
Wed Apr 22Benton SusandirectorSell24,367$0.00243,894
Wed Apr 22Bennett JeandirectorSell24,367$0.00259,019
Wed Apr 22Ainsworth SeandirectorSell24,367$0.00321,692
Wed Mar 18Zaremba Rabourn Amyofficer: Head of Fin. Quality AssuranceSell2,816$5.25190,312